|
Originally published In Press as doi:10.1074/jbc.M002671200 on May 25, 2000
J. Biol. Chem., Vol. 275, Issue 33, 25523-25532, August 18, 2000
Poliovirus RNA-dependent RNA Polymerase
(3Dpol)
STRUCTURAL, BIOCHEMICAL, AND BIOLOGICAL ANALYSIS OF CONSERVED
STRUCTURAL MOTIFS A AND B*
David W.
Gohara §,
Shane
Crotty¶ ,
Jamie J.
Arnold ,
Joshua D.
Yoder ,
Raul
Andino¶, and
Craig E.
Cameron **
From the Department of Biochemistry and Molecular
Biology, Pennsylvania State University, University Park, Pennsylvania
16802 and ¶ Department of Microbiology and Immunology, University
of California, San Francisco, California 94143
Received for publication, March 29, 2000, and in revised form, May 10, 2000
 |
ABSTRACT |
We have constructed a structural model for
poliovirus RNA-dependent RNA polymerase
(3Dpol) in complex with a primer-template
(sym/sub) and ATP. Residues found in conserved structural motifs A
(Asp-238) and B (Asn-297) are involved in nucleotide selection. Asp-238
appears to couple binding of nucleotides with the correct sugar
configuration to catalytic efficiency at the active site of the enzyme.
Asn-297 is involved in selection of ribonucleoside triphosphates over 2'-dNTPs, a role mediated most likely via a hydrogen bond between the
side chain of this residue and the 2'-OH of the ribonucleoside triphosphate. Substitutions at position 238 or 297 of 3Dpol
produced derivatives exhibiting a range of catalytic efficiencies when
assayed in vitro for poly(rU) polymerase activity or
sym/sub elongation activity. A direct correlation existed between
activity on sym/sub and biological phenotypes; a 2.5-fold reduction in polymerase elongation rate produced virus with a temperature-sensitive growth phenotype. These data permit us to propose a detailed, structural model for nucleotide selection by 3Dpol, confirm
the biological relevance of the sym/sub system, and provide additional
evidence for kinetic coupling between RNA synthesis and subsequent
steps in the virus life cycle.
 |
INTRODUCTION |
All nucleic acid polymerases, with the exception of mammalian DNA
polymerase , have the same overall topology (1). As suggested first
by Steitz in his description of the Klenow fragment of DNA polymerase I
(KF)1 (2), these enzymes
resemble a cupped, right hand with fingers, palm, and thumb subdomains.
The fingers and thumb subdomains contribute to substrate binding,
especially to regions of primer and template remote from the catalytic
center (3-7). The palm subdomain of all classes of polymerase contains
structural elements necessary for phosphoryl transfer and binding to
primer, template, and nucleotide (8-12). The overall structure and, to
some extent, sequence of palm subdomains are also highly homologous.
Thus, the functional similarity between the kinetic and chemical
mechanism of nucleic acid polymerases is not surprising (13-17).
Nucleic acid polymerases are categorized based upon their specificity
for template and nucleotide. Of course, specificity is a relative term,
since it is quite dependent upon reaction conditions. At
physiologically relevant values of pH and ionic strength and in the
presence of Mg2+ ions, most DNA-dependent DNA
polymerases prefer to utilize DNA templates and
2'-deoxyribonucleotides (2'-dNTPs) as substrates rather than RNA and
ribonucleotides (rNTPs) (18). The converse is true for
RNA-dependent RNA polymerases (RdRPs) (19, 20).
However, even under physiological conditions, exceptions to polymerase
specificity have been noted, especially for primer and/or template
utilization. For example, KF utilizes RNA templates (21), T7
DNA-dependent RNA polymerase (DdRP) utilizes RNA templates (22), and poliovirus RdRP utilizes DNA primers (20). Template preference becomes even more ambiguous when alternative divalent cations, such as Mn2+, are employed (20). This "identity
crisis" of polymerases regarding template utilization is not too
surprising given the existence of enzymes like reverse transcriptases
(RTs) that bridge both worlds (23). Moreover, the ease of polymerases
to move from one template type to another was probably a driving force
for the evolution of specific protein-nucleic acid and protein-protein interactions as an obligatory step for the initiation of transcription, replication, and repair (24).
In contrast to template selection, nucleotide selection is more
stringent under physiological conditions. For example, T7 DdRP exhibits
an 80-fold preference for rNTPs relative to 2'-dNTPs (25). KF exhibits
a 103 to 106-fold preference for 2'-dNTPs
(26-28). The reverse transcriptases from human immunodeficiency virus
(HIV-1) and Moloney murine leukemia virus (MMLV) exhibit a
105-fold preference for 2'-dNTPs (29, 30). The use of
Mn2+ as divalent cation permits all classes of polymerase
to incorporate one or two nucleotides of the incorrect sugar
configuration (31-36). However, processive incorporation of
nucleotides of the incorrect sugar configuration is not tolerated (37,
38).
The molecular basis for nucleotide selection by polymerases has been a
topic of considerable interest recently (39-43). This interest has
resulted from the development of structural models for
DNA-dependent DNA polymerases and a DdRP in complex with
various substrates (e.g. primer, template, and/or
nucleotide). These studies have uncovered interactions between the
enzyme and nucleotide that may be important during the selection
process (5-9). Construction and characterization of site-directed
mutants of KF, HIV-1 RT, and MMLV RT have confirmed the structural
predictions by altering the 2'-dNTP/rNTP preference of these enzymes.
The 2'-dNTP-utilizing enzymes use a steric gating mechanism to decrease
the affinity of the enzyme for rNTPs (27, 28, 40). The steric gate is formed, in part, by a residue found in structural motif A (motif designations are as defined by Hansen et al. (1)) of the
palm subdomain (KF Glu-710, HIV-1 RT Tyr-115, MMLV RT Phe-155).
Structural motif B of the palm subdomain may also participate in this
process (43).
The mechanism employed by rNTP-utilizing enzymes is not fully
understood. A steric gating mechanism has been proposed for T7 DdRP.
Succinctly, it has been suggested that a water molecule bound to
Tyr-639, a residue that occludes the nucleotide-binding pocket, is
displaced as a consequence of rNTP binding. Displacement of this water
molecule results in movement of Tyr-639 out of the pocket, thereby
permitting productive rNTP binding. The absence of a 2'-OH would not
permit induction of this conformational transition, thereby creating a
steric block to productive binding of 2'-dNTPs (25, 44). Although this
model is based upon steady-state kinetic analysis of T7 RNA polymerase
derivatives, a water molecule and movement of Tyr-639 have been
observed crystallographically (45, 46).
An alternative model has been proposed recently for rNTP selection by
T7 DdRP based solely upon structural observations. Selection for rNTP
binding appears to be mediated by a hydrogen-bonding network consisting
of the 2'-OH and side chains of the enzyme (His-784 and Tyr-639). Such
a network is more consistent with the 80-fold preference of this enzyme
for rNTPs (25, 47). An 80-fold difference in specificity corresponds to
a free energy difference of approximately 3 kcal/mol, a reasonable
value for one or two hydrogen bonds (67). Moreover, as discussed above, steric mechanisms yield specificity differences that are, on average, 4000-fold greater than that observed for this enzyme. Aspects of these
two models are mutually exclusive. Analysis of His-784 derivatives
under conditions in which 2'-dNTP incorporation by the wild-type enzyme
is observed should help to distinguish between these two models
(45).
Currently, information regarding the mechanism of nucleotide selection
by the RdRP is not available. Our previous work has shown that the RdRP
from poliovirus utilizes rNTPs at least 121-fold more efficiently than
2'-dNTPs (48). This value is similar to that determined for T7 DdRP. In
addition, Hansen et al. have predicted the use of a
hydrogen-bonding network to select for rNTP binding based upon the
unliganded structure of this enzyme (1). In this report, we have used
the structure for the ternary complex of HIV-1 RT to develop a model
for the ternary complex of poliovirus RNA polymerase. In addition, we
use biochemical and biological analysis of site-directed mutants of
3Dpol to test predictions of this model. This analysis
demonstrates a role for conserved structural motifs A and B in
2'-dNTP/rNTP selection by the RdRP. In addition, we provide additional
support for the biological relevance of the primer-template (sym/sub) system developed to study the RdRP from poliovirus in vitro
(48).
 |
EXPERIMENTAL PROCEDURES |
Materials--
[ -32P]UTP (>6,000 Ci/mmol) was
from NEN Life Science Products; [ -32P]ATP (>7,000
Ci/mmol) was from ICN; nucleoside 5'-triphosphates (ultrapure
solutions) were from Amersham Pharmacia Biotech, Inc.; all DNA
oligonucleotides and T4 DNA ligase were from Life Technologies, Inc.;
all RNA oligonucleotides were from Dharmacon Research, Inc. (Boulder,
CO); restriction enzymes, T4 polynucleotide kinase, and Deep Vent DNA
polymerase were from New England Biolabs, Inc.; polyethyleneimine-cellulose TLC plates were from EM Science; and 2.5-cm
DE81 filter paper discs were from Whatman. All other reagents were of
the highest grade available from Sigma or Fisher.
Construction of the 3Dpol Ternary Complex
Model--
The coordinates for the HIV-1 RT ternary complex (1rtd) and
3Dpol (1rdr) are available from the Research Collaboratory
for Structural Bioinformatics. Superpositioning of the two structures
was performed using lsqkab from the CCP4 suite of programs (49).
Structural alignments were initially performed using the thumb and palm
subdomains. Final superpositioning of the two structures was confined
to structural motifs A (3Dpol residues 233-240), B
(), C (324), and E (). The final positions of
C- atoms in the four structural motifs had a root mean square deviation ranging from 0.9 to 1.8 Å.
3Dpol residues were inserted into the structurally
analogous positions of HIV-1 RT using the program O (50). Residues
having the same identity in both structures were not altered from those observed in the HIV-1 RT structure. Amino acids unique to
3Dpol were manually set in position based on their
orientation in the unliganded 3Dpol structure. In some
instances, the side chains were adjusted to eliminate steric contact
with neighboring residues. 2'-OHs were inserted into both the primer
and template strands of the nucleic acid within the polymerase active
site as well as the incoming nucleotide. Bond angles for the 2'-OHs
were adopted from various RNA structures determined using NMR and x-ray
crystallography obtained from the Research Collaboratory for Structural
Bioinformatics. Within the vicinity of the active site, DNA in the
HIV-1 RT structure adopts an A-form conformation causing the sugar
pucker to switch from C2'-endo to C3'-endo; hence, modification of the
sugar geometry was not necessary. Nucleotide bases of the RNA were
modified to correspond to that of sym/sub (48), 5'-GCAUGGGCCC-3', and
the incoming nucleotide was modified to ATP, the first nucleotide incorporated into sym/sub. Two additional regions (comprising residues
163-202) were modeled into the structure based on a partial structural
and sequence alignment. Region I, residues 175-202, was identified by
superpositioning of the 3Dpol and HIV-1 RT structures and
consists of an extended -helix that runs underneath the 3'-end of
the template strand. Region II comprises residues 163-174 (which are
absent from the 3Dpol structure), which represent the
active site side of the fingers subdomain.
Energy minimizations were performed on the entire structure, comprising
both modified and unmodified regions, using the program CNS SOLVE (51).
Initial attempts at energy minimization were performed on the modified
region of the structure only; however, upon completion of the first
cycle, gross distortions of the molecule were observed. The modified
region was reinserted into the entire HIV-1 RT structure, and energy
minimizations were repeated. The additional structure eliminated
distortions in the molecule, allowing the protein side chains to relax
into positions void of unfavorable, steric contact. Iterative cycles of
minimization, a total of 10, were performed using the constant
temperature algorithm. The final settings for the energy minimization
follow. The Cartesian (restrained) molecular dynamics algorithm was
utilized at a constant temperature (298 K) using the coupled
temperature control method (52). 10,000 molecular dynamics steps were
performed at 0.0005-ps intervals. The dielectric was set to 1 (the
default value), and the number of trials utilizing different initial
velocities was set to 1. The output files from each cycle were
superimposed to observe side chain and nucleic acid motions, which were
most apparent for side chains and nucleotides not involved in protein
or nucleic acid interactions. Upon completion of the final cycle of
minimization, the modified region was removed from the structure, and
side chain geometry was checked using the program PROCHECK (53).
Finally, the modified regions of the HIV-1 RT structure, as well as
nucleic acid, nucleotide, and Mg2+ ions were removed
from the file and used to generate a new Protein Data Bank file (3DRTSS).
Construction, Expression, and Purification of 3Dpol
Derivatives--
Mutations were introduced into a modified
3Dpol-coding sequence by using overlap-extension PCR (54)
and expressed in Escherichia coli by using a ubiquitin
fusion system. The ubiquitin fusion system, PCR conditions, and
modified gene have been described previously (55). The D238F clone was
engineered such that it contained a silent NheI site. The
sequence of the forward oligonucleotide is 5'-GAC TAC ACA GGG TAT
TTC GCT AGC CTC AGC CCT-3'; the codon changing
Asp to Phe is underlined, and the NheI site is in boldface
type. A wild-type reverse oligonucleotide was employed (oligonucleotide
10, Table I). Briefly, two separate PCR reactions were performed: one
reaction with the pET-Ub-SacII for oligonucleotide and the
Asp-238 WT rev; the other with D238 wild-type rev for and
pET-3D-BamHI rev. Both reactions employed pET26b-Ub-3D (55) as
template. Products were purified by agarose gel electrophoresis and
used as the template in the next round of PCR with a 1:10 molar ratio
of the wild-type:D238F-modified fragments. The AflII for and
AvrII reverse oligonucleotides were used as the sole primers for this cycle of PCR. Product was purified, digested with
AvrII and AflII, and ligated into pET26b-Ub-3D
that had been digested with the same restriction enzymes. Plasmids were
screened for the presence of the NheI site. The remaining
mutant 3Dpol genes were constructed by using PCR as
described above and subcloned into the D238F vector between the
AflII and AvrII restriction sites and screened
for the loss of the NheI site. Mutations were confirmed by
DNA sequencing (Nucleic Acid Facility, Pennsylvania State University).
3Dpol derivatives were expressed and purified as described
previously (55) with the following modifications. 100-ml cultures were
lysed by using a French press, nucleic acid was removed by precipitation with polyethyleneimine, and supernatants were clarified by ultracentrifugation (55). 3Dpol was precipitated by the
addition of solid ammonium sulfate to 40% saturation. Recovered
pellets were suspended and passed over a 3-ml phosphocellulose column.
Bound protein was eluted from the phosphocellulose column by using
column volume (500 µl) of 50 mM HEPES, pH 7.5, 10 mM dithiothreitol, 20% glycerol, 0.1% Nonidet P-40,
and 200 mM NaCl. The proteins were >90% pure based upon
SDS-polyacrylamide gel electrophoresis analysis. Two of the derivatives
(D238A and N297A) were purified using the complete purification
procedure (55) to >95% purity. The N297F derivative was not soluble
when induced in E. coli at 25 °C. The concentration of
all 3Dpol derivatives was determined by absorbance at 280 nm using a calculated extinction coefficient of 71,480 M 1 cm 1
(56). The concentration of enzyme stocks prepared by using the
abbreviated procedure ranged from 43 to 51 µM.
Purity of
[ -32P]UTP--
[ -32P]UTP was diluted
to 0.1 µCi/µl in distilled deionized H2O, and 1 µl
was spotted in triplicate onto TLC plates. TLC plates were developed in
0.3 M potassium phosphate, pH 7.0, dried, and exposed to a
PhosphorImager screen (Molecular Dynamics, Inc., Sunnyvale, CA).
Imaging and quantitation were performed by using the ImageQuant
software from Molecular Dynamics. The purity was used to correct the
specific activity of UTP in reactions in order to calculate accurate
concentrations of product.
Poly(rU) Polymerase Activity Assays--
Reactions contained 50 mM HEPES, pH 7.5, 10 mM 2-mercaptoethanol, 5 mM MgCl2 or MnCl2, 60 µM ZnCl2, 500 µM UTP, 0.4 µCi/µl [ 32-P]UTP, 1.8 µM
dT15/2 µM rA30 primer-template,
and 3Dpol. Reactions were carried out in a total volume of
25 µl with 250 ng of enzyme at 30 °C for 5 min. Reactions were
quenched by the addition of 5 µl of 0.5 M EDTA. 10 µl
of the quenched reaction was spotted onto DE81 filter paper discs and
dried completely. The discs were washed three times for 10 min in 250 ml of 5% dibasic sodium phosphate and rinsed in absolute ethanol.
Bound radioactivity was quantitated by liquid scintillation counting in
5 ml of EcoScint scintillation fluid (National Diagnostics).
5'-32P Labeling of Oligonucleotides--
RNA
oligonucleotides were end-labeled using [ -32P]ATP and
T4 polynucleotide kinase essentially as specified by the manufacturer. Reactions typically contained 11 µM
[ -32P]ATP, 10 µM RNA oligonucleotide,
and 0.4 units/µl T4 polynucleotide kinase. Unincorporated nucleotide
was removed by passing the sample over two consecutive 1-ml Sephadex
G-25 (Sigma) spun columns.
Kinetics of Single Ribo- and Deoxyribonucleotide
Incorporation--
Rates of nucleotide incorporation were determined
using a synthetic RNA oligonucleotide primer-template (sym/sub) (48). Reactions were performed either on the bench top or in an RQF-3 rapid
quenching/mixing device (KinTek Corp., Austin, TX) (57). Enzyme-nucleic
acid complexes were preformed by incubating 2 µM end-labeled sym/sub and 2 µM enzyme for 90-200 s at
30 °C in 50 mM HEPES, pH 7.5, 5 mM
MgCl2 or MnCl2, 10 mM
-mercaptoethanol, 60 µM ZnCl2. Reactions
were initiated by the addition of an equal volume of nucleotide in the
above buffer. At indicated times, the reaction was quenched by the
addition of 0.5 M EDTA to a final concentration of 0.3 M.
Denaturing Polyacrylamide Gel Electrophoresis--
10 µl of
the quenched reaction was added to 10 µl of loading buffer: 90%
formamide, 50 mM Tris borate, 0.025% bromphenol blue, 0.025% xylene cyanol. Samples were heated to 70 °C for 2-5 min prior to loading 5 µl on a 23% polyacrylamide, 1.5% bisacrylamide, 7 M urea gel. Electrophoresis was performed in 1× TBE (89 mM Tris, pH 8.0, 10 mM boric acid, 2 mM EDTA) at 75 watts. Gels were visualized by using a
PhosphorImager (Molecular Dynamics) and quantitated by using ImageQuant
software (Molecular Dynamics).
Data Analysis--
Data were plotted using the program
Kaleidagraph (Synergy Software, Reading, PA). The rate of nucleotide
incorporation (kobs) was determined by fitting
the data to a single exponential, kobs = A × exp kt + C, where
A represents the maximum amplitude, k represents
the observed rate of nucleotide incorporation, and t
represents time. The maximum rate of nucleotide incorporation
(kpol) and the apparent binding constant
(Kd) were determined by replot of
kobs versus [nucleotide] and fit to
the following equation: kobs = ((kpol × [nucleotide])/(Kd + [nucleotide])).
Construction of Mutated Viral cDNA Clones
(pMo-3D)--
Cloning of mutated 3Dpol-coding sequence
into the plasmid containing the full-length cDNA of poliovirus
(pMoRA, also known as pXpA-rib+polyAlong (58)) required
subcloning into an intermediate pUC plasmid due to conflicting
restriction sites in the pMoRA plasmid. BglII and
ScaI restriction sites were introduced into a pUC18 plasmid
by insertion of a synthetic linker between the BamHI and EcoRI sites of this vector. The linker oligonucleotides
(oligonucleotides 17 and 18, Table I) were annealed prior to ligation.
ScaI was used to screen clones for the presence of the
linker. The cDNA encoding the 3CD region of the wild-type Mahoney
strain of poliovirus was PCR-amplified from pMoRA using the DNA
oligonucleotides: pMoEcoRI rev (oligonucleotide 19, Table I) and
pMoBglII for (oligonucleotide 20, Table I). The PCR product was ligated
into the modified pUC18 vector using the BglII and
EcoRI restriction sites. The entire insert was sequenced,
and this construct was designated pUC-3CD.
Each mutated 3Dpol-coding sequence was PCR-amplified from
the appropriate pET26b-Ub-3D plasmid using the DNA oligonucleotides: N-Term-Ub (oligonucleotide 21, Table I) and pET-3D-rev (oligonucleotide 22, Table I). The PCR product was
digested with BstBI and MfeI and ligated into
appropriately digested pUC-3CD. The mutated viral cDNA clones were
constructed by subcloning the BglII-EcoRI
fragment from pUC-3CD into pMoRA. These final constructs were sequenced from the BstBI site through the MfeI site.
Construction of Mutated Replicons (pRLuc-3D)--
The pRLuc-3D
clones were constructed by subcloning the
BglII-ApaI fragment from pMo-3D constructs
containing the mutated 3D genes into pRLucRA (also known as
pRLuc31-rib+polyAlong) (58, 59).
Cells and Transfections--
HeLa S3 (ATCC stock plus
10-30 passages) were propagated in DMEM/F-12 (Life Technologies, Inc.)
supplemented with 10% fetal calf serum (Life Technologies), always
keeping the cultures between 20 and 80% confluence. For infectious
center assays, viral RNA was produced by in vitro
transcription of linearized plasmids (pMoRA wild-type plasmid or the
appropriate pMo-3Dpol derivative) using T7 RNA polymerase
as described (60). 10 µg of each viral RNA transcript was
electroporated into 1.2 × 106 HeLa cells in 400 µl
in a 0.2-cm cuvette using electroporation settings of 950 microfarads,
24 ohms, and 130 V on a BTX electroporator, giving an average pulse
length of 5 ms. Electroporated cells were separately diluted (10-fold)
in phosphate-buffered saline, and 100 µl of appropriate dilutions
(10 1 to 10 5) was
plated on 2 × 105 HeLa cells (prepared 1 day in
advance) in six-well dishes (a total volume of 0.5 ml). The remainder
of the undiluted electroporated cells were also plated. Cells were
allowed to adsorb to the plate for 1-2 h at 37 °C or 32 °C, and
then the medium/phosphate-buffered saline was aspirated, and the cells
were overlaid with 3 ml of a mixture of 1× DMEM/F-12 plus 10% fetal
calf serum and 1% agar. Infectious center assays were then incubated
at 37 °C or 32 °C for 2 days (wild type at 37 °C), 3 days
(wild-type at 32 °C), or 7 days (3Dpol mutant viruses).
Plates were stained with the vital dye crystal violet, and viral
plaques were counted.
Replicon transfections were performed using polioLuc RNA transcribed
from the plasmid pRLucRA (58) or the pRLuc-3D derivatives detailed
above using electroporation conditions described above. 1 × 105 cells were added per well to six-well dishes in
prewarmed (37 or 32 °C) DMEM/F-12 plus 10% fetal calf serum medium.
Cells were harvested at various times by centrifugation at 14,000 × g for 2 min in an Eppendorf microcentrifuge and
lysed in 100 µl of 1× cell culture lysis reagent (Promega, Madison,
WI) on ice for 2 min, and cellular debris and nuclei were removed by
centrifugation at 14,000 × g for 1 min. Lysates were
left on ice at 4 °C until all time points were collected. Lysates
were diluted 1:100 in H2O and assayed for luciferase
activity after mixing 10 µl of lysate with 10 µl of luciferase
assay substrate (Promega) by using an OptocompI luminometer (MGM).
 |
RESULTS AND DISCUSSION |
Model for the Ternary Complex of 3Dpol--
As a first
step toward elucidating the structure-function relationships of the
RNA-dependent RNA polymerase from poliovirus (3Dpol), we constructed a model of a complex comprising the
enzyme, primer-template, and nucleotide. The final structural model
consists of structural motifs A, B, C, and E, nucleic acid
primer-template, incoming nucleotide, and Mg2+ ions. In
addition, an extended -helix that supports the template strand, the
loop leading into motif B, and the active site portion of the
fingers subdomain were constructed. The last two elements were missing
in the 3Dpol structure (1) (Fig.
1A).

View larger version (41K):
[in this window]
[in a new window]
|
Fig. 1.
Structural model for the ternary complex of
3Dpol. A, structural model for
3Dpol complex with RNA primer-template (sym/sub), ATP, and
Mg2+. Model construction is described under "Experimental
Procedures." Structural motifs are color-coded according to Hansen
et al. (1) as follows: red, motif A
(residues 233-240); green, motif B ();
yellow, motif C (324); dark purple, motif E
(). The proposed active site portion of the fingers subdomain
(motif F, 163-182) and the -helical extension () are
colored gray. Primer, template, and ATP are shown as
stick models, and color coding is as follows:
red, oxygen; blue, nitrogen; orange,
phosphorus; gray, carbon. Metal ions A and B are shown as
magenta spheres. For clarity, only the last two
nucleotides on the 3'-end of the primer are shown. B,
proposed function of a glycine residue in the "GDD" motif (motif C)
and conserved residues in motif F. Van der Waal's projection of the
strictly conserved glycine (yellow surface) of
motif C (yellow strand) at the 3'-end of the
primer. Met-184 of HIV-1 RT has been superimposed into the model
(blue stick and surface). The presence
of the bulky side chain of methionine would sterically occlude the
2'-OH at the 3'-end of the primer strand. Asp-328 and the 3'-OH of the
primer strand help to coordinate metal ion at site A (see Fig.
1A). The 3'-OH is positioned for an in-line attack of the
-phosphorus of the incoming nucleotide. Lys-167 and Arg-174 on motif
F (gray strand) are shown hydrogen-bonding to
oxygens of the - and -phosphates of the incoming nucleotide. The
numbers shown are hydrogen bond distances (in Ångstroms).
All structural diagrams were generated using the program WebLabViewer
(Molecular Simulations Inc., San Diego, CA).
|
|
This model contains features that offer insight into the roles of
conserved residues of the RdRP. RdRPs contain a signature GDD motif
(structural motif C) consisting of a strictly conserved glycine
(Gly327) as well as an aspartic acid (Asp328).
A structurally analogous aspartic acid has been observed at this
position in all nucleic acid polymerases studied to date; however, the
role of the conserved glycine in the RdRP remains unclear. Comparison
of the 3Dpol ternary complex model with the HIV-1 RT
ternary complex structure offers insight into the functional
significance of a glycine at this position. In the 3Dpol
model, the presence of a bulky side chain, such as methionine, would
clash with the 2'-OH on the primer strand (Fig. 1B).
While the fingers subdomain is not present in the unliganded structure
for 3Dpol, superpositioning of the two structures results
in the alignment of an extended -helix (3Dpol residues
183-202) with a -strand (HIV-1 RT residues 78-94). In HIV-1 RT,
this -strand leads into a segment of the enzyme that forms the
active site side of the fingers subdomain, referred to here as the
flap ( 3- 4). Sequence homology permitted the assignment
of 3Dpol residues 163-174, which correspond to the flap of HIV-1 RT. Recently, the complete structure for the RdRP from
hepatitis C virus (HCV NS5B) was determined (10, 11). Structural
comparisons of the fingers region of NS5B and HIV-1 RT identified a new
structural motif (motif F) (11). The assignment of residues 163-174 of 3Dpol to motif F is in agreement with structural
information now available for NS5B. Conserved, basic residues located
in motif F of 3Dpol, Lys-167 and Arg-174, are predicted to
make contact with the phosphate moiety of the incoming nucleotide,
consistent with interactions observed in the HIV-1 RT ternary complex
structure (Fig. 1B) (7).
Nucleotide cross-linking studies with 3Dpol have suggested
that another conserved residue, Lys-66, is required for activity both in vitro and in vivo and may be in direct contact
with the incoming nucleotide (61). While the Lys-66 side chain is
disordered in the 3Dpol structure, structural and sequence
homology to NS5B would place this residue at the border of the NTP
channel leading to the polymerase active site. Modeling of nucleic acid
and nucleotide into the NS5B structure places the analogous residue to
Lys-66, Lys-56, approximately 3.0 Å away from the incoming nucleoside
triphosphate (data not shown). Lys-66 may therefore be required to
direct the incoming nucleotide into the active site and/or stabilize
the tripolyphosphate moiety by making contact with oxygens on the -phosphate.
DNA polymerases most likely select for 2'-dNTPs by using a steric
gating mechanism that excludes the bulky 2'-OH present on rNTPs.
Residues in conserved structural motifs A and B appear to be important
mediators of the selection against rNTP binding (27, 29, 62). Mutation
of Glu-710 (KF) and Phe-155 (MMLV RT) to alanine and valine,
respectively, produces derivatives that are less likely to discriminate
against a rNTP when compared with the wild-type enzyme (27, 30). While
these enzymes are capable of incorporating a rNTP more efficiently than
their wild-type counterparts, multiple cycles of rNTP incorporation may
be prohibited by the steric interactions with residues on motif C (see above).
Based upon structural homology to residues in DNA polymerases, it was
put forward that Asp-238 and Asn-297 of 3Dpol are important
for nucleotide selection at the 2'-position of the rNTP (1).
Specifically, it was suggested that selection for the presence of a
2'-OH is mediated by a hydrogen-bonding network; Asp-238 is positioned
in the active site by Asn-297 to hydrogen-bond to the 2'-OH of the
incoming rNTP (1) (Fig. 2A). In contrast to the unliganded structure, the final model for the ternary complex of 3Dpol shows Asp-238 hydrogen bonding to
a highly conserved threonine (Thr-293), while Asn-297 is interacting
with the 2'-OH of the incoming nucleotide (Fig. 2B). In
addition, an interaction between the Asp-238 backbone amide and the
3'-OH is also predicted (Fig. 2B); a similar interaction has
been observed in the RT ternary complex (7). This hydrogen bond will
not form based upon the conformation of this residue in the unliganded
structure (Fig. 2A) (1). Given the difference between the
unliganded structure and the model (Fig. 2C), substitutions
were made at both positions to determine the functional significance of
a hydrogen bond between these two residues. Furthermore, because both
residues are strictly conserved in the supergroup I and III RdRPs and
highly conserved in supergroup II polymerases (63), functional analysis
of these amino acids is important to begin to understand the roles of
these conserved side chains which line the nucleotide-binding
pocket.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 2.
Analysis of the unliganded structure and
ternary complex model of 3Dpol. A, Asp-238
(motif A) and Asn-297 (motif B) are shown interacting at a distance of
3.0 Å, based on a modified version (see below) of the coordinate file
for the unliganded structure of 3Dpol (1); Thr-293 (motif
B) is approximately 4.5 Å away from Asp-238. Superpositioning of the
unliganded 3Dpol structure onto the ternary complex
structure of HIV-1 RT shows steric clash between Asp-238 and the 2'-
and 3'-OHs of the nucleotide. To avoid unfavorable steric contact,
either the side chain of Asp-238 must move relative to the incoming
nucleotide or the position of the nucleotide itself must be altered.
However, the position of the nucleotide in the active site is
constrained by hydrogen bonds between the phosphate moiety and the
protein backbone, the position of the 3'-OH of the primer relative to
the -phosphate, and hydrogen bonding/stacking interactions of the
base. A similar motion of Asp-225 (Asp-238 homologue) in NS5B is also
required given the above constraints. B, the ternary complex
model indicates that Asp-238 is a distance of 2.8 Å from Thr-293,
while Asn-297 is within hydrogen bonding distance (3.3 Å) of the 2'-OH
of the incoming nucleotide (ATP). The 3'-OH and an oxygen of the
-phosphate are within hydrogen bonding distance. C,
superposition of the unliganded 3Dpol structure
(dark gray) with the ternary complex model
(light gray) predicts a conformational change of
the enzyme after rNTP binding. D, proposed model for rNTP
selection. Asn-297 hydrogen bonds to the 2'-OH of the incoming rNTP.
Asp-238 is within hydrogen bonding distance of the 2'-OH of the
incoming nucleotide in a conformation that is stabilized by hydrogen
bonds to Thr-293 as well as the backbone amide of Ser-288. The 3'-OH of
the incoming nucleotide makes contact with the backbone amide of
Asp-238 and is within hydrogen bonding distance of the oxygen on the
-phosphate, thus providing a link between the nucleotide-binding
pocket and the catalytic center of 3Dpol.
|
|
Rationale for Mutations--
In order to test the functional
significance of the hydrogen-bonding interaction between Asp-238 and
Asn-297, a series of mutations were introduced into
3Dpol-coding sequence. These mutations changed Asp-238 to
alanine, asparagine, glutamic acid, phenylalanine, or valine or changed Asn-297 to alanine, aspartic acid, glutamine, phenylalanine, or valine.
Alanines were substituted at either position (D238A or N297A) such that
a hydrogen bond between Asp-238 and Asn-297 would be disrupted. The
structurally analogous residues of the DNA-dependent DNA
polymerases (D238E or N297Q) and reverse transcriptases (D238F or
N297F) were substituted. If a steric interaction and not a hydrogen
bond is important for activity, then substitution of valine may be
sufficient for 3Dpol activity (D238V or N297V). Finally,
substitution of the pairing partner of either two residues (D238N or
N297D) may be sufficient to retain the hydrogen bond and have little
effect on activity. If a hydrogen bond between Asp-238 and Asn-297 is
required for rNTP selection, then substitutions at either position that
would disrupt hydrogen bonding should result in 3Dpol
derivatives that have equivalent phenotypes.
Activity on Homopolymeric Primer-Templates--
In order to assess
the effects of substitutions at positions 238 and 297 on polymerase
activity, we evaluated the (dT)15-primed poly(rU)
polymerase activity of each 3Dpol derivative by using a
dT15-rA30 primer-template (21). If a hydrogen
bond between Asp-238 and Asn-297 is required for polymerase function,
then substitutions at either position should equally impair polymerase
activity. However, an equivalent phenotype was not observed.
Substitutions at position 238 almost completely abolished activity
(1-7% of wild type), while substitutions at position 297 had only
moderate effects (20-80% of wild type) (Table II).
View this table:
[in this window]
[in a new window]
|
Table II
Poly(rU) polymerase activity of wild-type 3Dpol and
3Dpol derivatives determined by using dT15/rA30
Specific activities were determined as described under "Experimental
Procedures."
|
|
Derivatives containing substitutions that mimic the nucleotide-binding
site of DNA polymerases (D238F, D238E, and N297Q) were analyzed for
poly(dT) polymerase activity. Incorporation of dTMP was not observed
with any of the derivatives by using this assay (data not shown). It
was possible that incorporation of dNMPs required "proper"
positioning of the enzyme on the primer-template. In the previous
experiments, a DNA primer was employed. Perhaps an RNA primer could
support dNMP incorporation. To test this possibility, incorporation of
ribonucleoside monophosphates and dNMPs was evaluated by using an
(rU)15 primer. Again, dNMP incorporation was not observed (data not shown).
Changing Asp-225 of NS5B (Asp-238 homologue) to glycine or asparagine
resulted in a complete loss of activity (64). Changing Asp-240 of
encephalomyocarditis virus 3Dpol to glutamic acid produced
an enzyme with a 33-fold reduction in activity (65). However, based
upon poly(rU) polymerase activity, substitutions at the Asn-297
equivalent of 3Dpol resulted in either a complete loss of
activity or significantly reduced activity (6% of wild-type) for NS5B
and encephalomyocarditis virus 3Dpol, respectively. While
these results are in partial agreement with our observations,
alternative substrates were not available to evaluate these
substitutions further, making interpretation of these differences difficult.
It is possible that substitutions at Asp-238 may have resulted in large
rearrangements of the nucleotide-binding pocket. To test the catalytic
competence of the 3Dpol derivatives, Mn2+ was
substituted for Mg2+ in the poly(rU) polymerase assays,
because Mn2+ is known to stimulate wild-type
3Dpol (20). All of the derivatives could be stimulated in
the presence of Mn2+, albeit to various degrees (Table II).
Substitutions at Asn-297 could be stimulated to wild-type levels or
greater than wild-type levels observed in Mg2+. For three
of the five substitutions at Asp-238, approximately 75% of the
wild-type activity could be restored by using Mn2+. Two of
the derivatives (D238F and D238V) showed only a slight increase in
poly(rU) polymerase activity, suggesting that the presence of larger
hydrophobic residues at this position may, in fact, distort the
nucleotide-binding pocket. Taken together, these results suggest that
in most instances major structural rearrangements do not occur when
substitutions are made at positions 238 and 297 and that a
hydrogen bond between Asp-238 and Asn-297 is not absolutely required
for polymerase activity.
Activity on sym/sub--
While evaluation of poly(rU) polymerase
activity and related activities of 3Dpol derivatives is
useful as a first step, the fact that the rate-limiting step for this
reaction reflects template switching limits the utility of the
resulting data (19). We recently reported the development of a
symmetrical primer-template substrate (sym/sub) suitable for evaluation
of the kinetics and mechanism of 3Dpol-catalyzed RNA
synthesis (48). We have used this system to characterize further each
3Dpol derivative. The kinetics of AMP incorporation were
evaluated for each 3Dpol derivative at two concentrations
of ATP: 100 and 1000 µM. The Kd value
of wild-type 3Dpol for ATP is approximately 100 µM.2
The position 238 derivatives had the following order of activity:
D238A > D238E = D238N > D238F/D238V (Table
III). The D238A derivative was
400-900-fold less active than the wild-type enzyme. This reduction in
activity could not be attributed to defects in nucleotide binding for
this derivative (or any other), because a 10-fold increase in ATP
concentration never produced more than a 2-fold increase in the
observed rate of AMP incorporation.
View this table:
[in this window]
[in a new window]
|
Table III
Kinetics of AMP incorporation into sym/sub catalyzed by wild-type
3Dpol and 3Dpol derivatives
Rates were determined as described under "Experimental
Procedures."
|
|
The position 297 derivatives had the following order of activity:
N297D > N297V > N297A > N297Q (Table III),
representing a 2-70-fold reduction in activity relative to wild-type
3Dpol. This range of activity relative to wild-type
3Dpol is significantly different from the 2-5-fold
decrease in activity observed by using the poly(rU) polymerase assay.
This difference probably reflects a change in the rate-limiting step
measured by the different assays: template switching (poly(rU)
polymerase assay) (19) and elongation (sym/sub assay) (48).
The rates of single nucleotide incorporation were also determined by
using Mn2+ as the divalent cation cofactor at a single
concentration of ATP (100 µM). Mn2+ also
stimulated AMP incorporation into sym/sub for each derivative analyzed.
The relative order of activity of both position 238 and 297 derivatives
was consistent with that observed in Mg2+. However,
differences existed between the extent of Mn2+ rescue
observed by using the sym/sub assay relative to that observed by using
the poly(rU) polymerase assay. By employing preassembled 3Dpol-sym/sub complexes and an EDTA quench, the effect of
Mn2+ reflects the increased stability of the
3Dpol-sym/sub-ATP complex that undergoes
catalysis.3 In contrast, by
employing dT15/rA30, the effect of
Mn2+ reflects both an increase in the observed rate of
nucleotide incorporation due to a more stable ternary complex and a
decrease in the Km value for 3Dpol
binding to dT15/rA30 (19, 20).
By using sym/sub it is possible to determine the kinetic parameters,
kpol and Kd, for nucleotide
incorporation and calculate the specificity constant,
kpol/Kd. This analysis permits a more direct evaluation of the role of these residues in
nucleotide selection. Two derivatives were selected for analysis: D238A
and N297A. For this analysis, these two derivatives were purified by
using the complete purification procedure (55).
The wild-type enzyme utilizes AMP 216-fold better than dAMP (Table
IV). The selection by the enzyme for the
rNTP occurs primarily during incorporation (108-fold) rather than
binding (2-fold) (Table IV). The D238A derivative was incapable of
distinguishing ATP from dATP (Table IV). The
kpol value of this enzyme for both nucleotides was decreased 2000-fold relative to wild-type 3Dpol. This
difference may reflect a change in the rate-limiting step for this
derivative; perhaps the chemical step is now the rate-limiting step for
incorporation. If the rate of the chemical step is decreased, then the
apparent reduction in the Kd value for nucleotides may reflect the constant for a different species (intermediate) in the
reaction pathway rather than an increase in the affinity of the enzyme
for nucleotide (35).
View this table:
[in this window]
[in a new window]
|
Table IV
Kinetic parameters for AMP and dAMP incorporation into sym/sub by
wild-type 3Dpol and 3Dpol derivatives at 30 °C
Parameters were determined as described under "Experimental
Procedures."
|
|
These data are consistent with observations made by Joyce and
colleagues with Klenow fragment (26-28). Mutation of Glu-710 in this
enzyme to alanine resulted in an enzyme capable of incorporating rNTPs
(27, 28). However, the maximal rate of dNMP incorporation was
dramatically reduced relative to wild-type enzyme, suggesting a more
direct role for this residue in phosphoryl transfer (27, 28).
In contrast to the complex phenotype of the D238A derivative, the
phenotype of the N297A derivative is more easily interpreted. The role
of Asn-297 in 2'-OH selection is probably very similar to that
predicted for His-784 in T7 RNA polymerase (i.e. to
provide a direct hydrogen bond (46)). The N297A derivative had a
10-fold reduction in the ability to distinguish rNTPs from 2'-dNTPs
(Table IV). This reduction in specificity is due to a decrease in the efficiency of rNTP incorporation rather than a decrease in the affinity
of the enzyme for rNTPs (Table IV). It is possible that an interaction
between Asn-297 and the 2'-OH of the rNTP, as indicated in the
structural model (Fig. 2B), stabilizes the catalytically competent ternary complex. If this complex "opens" more frequently in the absence of this interaction, then the observed rate of incorporation would be reduced. A similar argument can be used to
explain the reduced rate of dNMP incorporation relative to ribonucleoside monophosphate incorporation for the wild-type enzyme (Table IV). The finding that the N297A derivative is only 10-fold slower than the wild-type enzyme instead of 100-fold suggests that an
additional residue may interact with the 2'-OH of the incoming rNTP. It
is possible that another residue (e.g. Asp-238) has this
function (1).
Model for Ribonucleotide Selection by 3Dpol--
In
Fig. 2D, we present our working hypothesis for the mechanism
of rNTP selection by 3Dpol. Upon binding of an rNTP to the
nucleotide-binding pocket, there may be a conformational change that
positions Asp-238 and Asn-297 within hydrogen-bonding distance of the
2'-OH and positions the backbone amide of Asp-238 within
hydrogen-bonding distance of the 3'-OH. A stable conformation of the
3'-OH may be required for hydrogen bonding to an oxygen of the
-phosphate, which, in turn, may facilitate phosphoryl transfer by
restricting the mobility of the tripolyphosphate. The position of the
Asp-238 side chain may be fixed by interactions with the side chain of
Thr-293 and the backbone amide of Ser-288.
Is there a hydrogen bond between Asp-238 and Asn-297? The data
presented herein are not sufficient to completely rule out this
possibility. However, for the following reasons, we have not included
this interaction in the model shown in Fig. 2D. First, it
was not possible to orient the carboxamide of Asn-297 such that it
interacted with both the 2'-OH of the rNTP and the carboxylate of
Asn-238. Second, our data showed that Asn-297 was not essential for
positioning Asp-238 (based upon the lack of equivalence of the
phenotypes for N297A and D238A) but was required for interactions with
the 2'-OH (Table IV). More rigorous analysis of the alanine derivatives, including kinetic analysis of the two derivatives with
nucleotide analogs, is in progress to clarify this issue.
We added the additional interactions shown in Fig. 2D to
explain the biochemical data reported in Tables II-IV. In the absence of Asn-297, Asp-238 remains in place, presumably due to other interactions in the pocket. Clearly, Thr-293 and Ser-288 are in a
position to function in this capacity. D238A is impaired in its ability
not only to select for rNTPs but also to catalyze phosphoryl transfer.
The ability of this side chain to communicate with the active site, a
distance of 10 Å, can be explained by the model as follows. The
conformation of the tripolyphosphate requires a stable conformation of
the 3'-OH, which is dependent upon the position of the Asp-238
backbone, and the position of the backbone is dependent upon the
conformation of the Asp-238 side chain. Such an intricate network of
hydrogen bonds should be capable of communicating to the active site
that a nucleotide with the incorrect sugar configuration has been
bound. In addition, given the close packing within the pocket, binding
of nucleotides with an incorrect base may also be communicated to the
active site by perturbing the position of Asp-238.
Activity In Vivo--
The poly(rU) polymerase assay showed that
the N297A, N297D, and N297Q derivatives retained 80, 60, and 20% of
the wild-type activity, respectively. If these values reflect the
biological activity, then it is reasonable to predict that the N297A
and N297D derivatives might support virus multiplication, while the N297Q might exhibit a delayed growth phenotype or not support any virus
growth. In contrast, the sym/sub assay showed that the N297A, N297D,
and N297Q derivatives retained 10, 40, and 1% of the wild-type
activity, respectively. Based upon these data, it is reasonable to
predict that virus containing a 3Dpol-N297D substitution
might be viable, but a virus containing 3Dpol-N297A or
3Dpol-N297Q might not. A series of poliovirus variants were
constructed containing these specific alterations in 3Dpol
to determine which of the two in vitro polymerase assays is
more relevant biologically.
The viability of the mutant polioviruses was determined by high
efficiency transfection with in vitro transcribed viral RNA. A productive infection was established in 4.3% (5 × 104) of the transfected cells by using wild-type poliovirus
RNA or the Mo Nde1 variant at 37 °C (Table
V), as scored in an infectious center
assay (see "Experimental Procedures").
Mo Nde1-3Dpol238A, Mo Nde1-3Dpol297A,
Mo Nde1-3Dpol297D, and Mo Nde1-3Dpol297Q
were all inviable at 37 °C (Table V). Transfections were repeated at
32 °C and showed that only Mo Nde1-3Dpol297D was
viable (Table V). Interestingly, Mo Nde1-3Dpol297D was
temperature-sensitive and only formed small plaques at 6 days after
transfection, 4 days slower than wild-type virus (Fig.
3A).

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 3.
Biological analysis of 3Dpol
variants. A, infectious center assay. HeLa cells were
transfected with viral RNA (Mo Nde1 or
Mo Nde1-3Dpol297D) and then serially diluted and plated
on a monolayer of untransfected HeLa cells. Plates were overlaid with
an agar/medium agar medium (no 1 ) (see "Experimental
Procedures") and incubated at 32 °C. Plates were developed on day
3 or day 6 after transfection. Plates containing transfected cells
plated at a 1000-fold dilution are shown. Pinpoint plaques are visible
on the Mo Nde1-3Dpol297D plate by day 6, when a
comparable Mo-transfected plate has been completely lysed. Plaque
assays were repeated numerous times. B, schematic diagram of
polioLuc. PolioLuc is a poliovirus replicon that consists of a
full-length poliovirus genome with the capsid genes replaced by a
luciferase reporter gene. Upon translation, the active luciferase
protein is cleaved away from the viral polyprotein by the viral
protease 2A. C, PolioLuc replicons at 37 °C. This
experiment was performed in triplicate, and a representative experiment
is shown. , wild-type polioLuc; , wild-type polioLuc plus 2 mM guanidine; , polioLuc-3Dpol238A; ,
polioLuc-3Dpol297A; , polioLuc-3Dpol297D.
D, PolioLuc replicons at 32 °C. Experiment was performed
in triplicate, and a representative experiment is shown.
Symbols are as in C.
|
|
To determine more directly the effect of these substitutions on RNA
synthesis, a poliovirus replicon (polioLuc) that consists of a
full-length poliovirus genome with the capsid genes replaced by a
luciferase reporter gene was employed (Fig. 3B). Upon
transfection into HeLa cells, polioLuc translates and replicates at
levels comparable with wild-type poliovirus (58). A representative set
of 3Dpol mutations were subcloned into the replicon
plasmid, and translation and replication of the corresponding RNAs were
evaluated at 37 and 32 °C (Fig. 3, C and D).
Poliovirus replication is inhibited by 2 mM guanidine.
Therefore, luciferase activity obtained from polioLuc transfection in
the presence of 2 mM guanidine is a measure of the
translation of the input RNA. RNA for all derivatives was translated at
wild-type levels. As expected, polioLuc-3Dpol238A
completely failed to replicate. PolioLuc-3Dpol297A
replicated to levels slightly above background at both 37 and 32 °C,
demonstrating a serious defect for replication in vivo. PolioLuc-3Dpol297D clearly replicated both at 32 and
37 °C but was 10-fold lower than wild-type replication levels at its
peak at 37 °C, whereas 50% of the wild-type replication level was
observed at 11 h after transfection at 32 °C (Fig. 3,
C and D).
Taken together, these data demonstrate a direct correlation between the
kinetics of elongation on sym/sub in vitro and the kinetics
of RNA synthesis in vivo. These results support the
hypothesis that sym/sub recapitulates the biologically relevant
elongation reaction. A 2.5-fold reduction in the elongation rate of
3Dpol confers a temperature-sensitive growth phenotype on
the virus. Changes at position 297 should affect nucleotide selection
and may also change the overall fidelity of this derivative relative to
wild-type 3Dpol. Therefore, additional studies with other
derivatives will be necessary to prove that the biological phenotype
associated with the virus containing the N297D substitution in
3Dpol is due solely to a defect in the rate of elongation.
Nevertheless, it is reasonable to conclude that complete inhibition of
viral RNA transcription and replication is not necessary to reduce
significantly virus production. Although the molecular basis for this
observation remains to be determined, it is intriguing to speculate
that the observed synergy is related to the kinetic coupling of RNA
synthesis and downstream processes such as packaging (66).
 |
ACKNOWLEDGEMENTS |
We thank Dr. Greg Farber for providing access
to graphics workstations, Dr. Hemant Yennawar for expert technical
assistance in various aspects of model construction, and Dr. Stephen
Harrison for providing access to coordinates prior to publication.
 |
FOOTNOTES |
*
This work was supported in part by NCI, National Institutes
of Health (NIH), Howard Temin Award CA75118 (to C. E. C.) and NIAID,
NIH, Grants AI45818 (to C. E. C.) and AI40085 (to R. A.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Predoctoral fellow supported by National Science Foundation
Research Training Grant DBI-902232.
Howard Hughes Medical Institute predoctoral fellow.
**
To whom correspondence should be addressed. Tel.: 814-863-8705;
Fax: 814-863-7024; E-mail: cec9@psu.edu.
Published, JBC Papers in Press, May 25, 2000, DOI 10.1074/jbc.M002671200
2
J. J. Arnold and C. E. Cameron,
manuscript in preparation.
3
J. J. Arnold, D. W. Gohara, and
C. E. Cameron, manuscript in preparation.
 |
ABBREVIATIONS |
The abbreviations used are:
KF, Klenow fragment;
rNTP, ribonucleoside triphosphate;
HIV-1, human immunodeficiency
virus-1;
RT, reverse transcriptase;
MMLV, Moloney murine leukemia
virus;
RdRP, RNA-dependent RNA polymerase;
DdRP, DNA-dependent RNA polymerase;
PCR, polymerase chain
reaction.
 |
REFERENCES |
| 1.
|
Hansen, J. L.,
Long, A. M.,
and Schultz, S. C.
(1997)
Structure
5,
1109-1122
|
| 2.
|
Ollis, D. L.,
Kline, C.,
and Steitz, T. A.
(1985)
Nature
313,
818-819
|
| 3.
| Eick, D., Wedel, A., and Heumann, H. (1994) Trends Genet.
292-296
|
| 4.
|
Hermann, T.,
Meier, T.,
Gotte, M.,
and Heumann, H.
(1994)
Nucleic Acids Res.
22,
4625-4633
|
| 5.
|
Doublie, S.,
Tabor, S.,
Long, A. M.,
Richardson, C. C.,
and Ellenberger, T.
(1998)
Nature
391,
251-258
|
| 6.
|
Kiefer, J. R.,
Mao, C.,
Braman, J. C.,
and Beese, L. S.
(1998)
Nature
391,
304-307
|
| 7.
|
Huang, H.,
Chopra, R.,
Verdine, G. L.,
and Harrison, S. C.
(1998)
Science
282,
1669-1675
|
| 8.
|
Doublie, S.,
and Ellenberger, T.
(1998)
Curr. Opin. Struct. Biol.
8,
704-712
|
| 9.
|
Boyer, P. L.,
Ferris, A. L.,
Clark, P.,
Whitmer, J.,
Frank, P.,
Tantillo, C.,
Arnold, E.,
and Hughes, S. H.
(1994)
J. Mol. Biol.
243,
472-483
|
| 10.
|
Ago, H.,
Adachi, T.,
Yoshida, A.,
Yamamoto, M.,
Habuka, N.,
Yatsunami, K.,
and Miyano, M.
(1999)
Struct. Fold. Des.
7,
1417-1426
|
| 11.
|
Lesburg, C. A.,
Cable, M. B.,
Ferrari, E.,
Hong, Z.,
Mannarino, A. F.,
and Weber, P. C.
(1999)
Nat. Struct. Biol.
6,
937-943
|
| 12.
|
Steitz, T. A.,
and Steitz, J. A.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
6498-6502
|
| 13.
|
Steitz, T. A.
(1999)
J. Biol. Chem.
274,
17395-17398
|
| 14.
|
Kuchta, R. D.,
Mizrahi, V.,
Benkovic, P. A.,
Johnson, K. A.,
and Benkovic, S. J.
(1987)
Biochemistry
26,
8410-8417
|
| 15.
|
Patel, S. S.,
Wong, I.,
and Johnson, K. A.
(1991)
Biochemistry
30,
511-525
|
| 16.
|
Reardon, J. E.
(1993)
J. Biol. Chem.
268,
8743-8751
|
| 17.
|
Jia, Y.,
and Patel, S. S.
(1997)
J. Biol. Chem.
272,
30147-30153
|
| 18.
|
Benkovic, S. J.,
and Cameron, C. E.
(1995)
Methods Enzymol.
262,
257-269
|
| 19.
|
Arnold, J. J.,
and Cameron, C. E.
(1999)
J. Biol. Chem.
274,
2706-2716
|
| 20.
|
Arnold, J. J.,
Ghosh, S. K.,
and Cameron, C. E.
(1999)
J. Biol. Chem.
274,
37060-37069
|
| 21.
|
Ricchetti, M.,
and Buc, H.
(1993)
EMBO J.
12,
387-396
|
| 22.
|
Arnaud-Barbe, N.,
Cheynet-Sauvion, V.,
Oriol, G.,
Mandrand, B.,
and Mallet, F.
(1998)
Nucleic Acids Res.
26,
3550-3554
|
| 23.
|
Joyce, C. M.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
1619-1622
|
| 24.
|
Kornberg, A.,
and Baker, T.
(1991)
DNA Replication
, 2nd Ed.
, W. H. Freeman and Co., New York
|
| 25.
|
Huang, Y.,
Eckstein, F.,
Padilla, R.,
and Sousa, R.
(1997)
Biochemistry
36,
8231-8242
|
| 26.
|
Minnick, D. T.,
Astatke, M.,
Joyce, C. M.,
and Kunkel, T. A.
(1996)
J. Biol. Chem.
271,
24954-24961
|
| 27.
|
Astatke, M.,
Grindley, N. D.,
and Joyce, C. M.
(1998)
J. Mol. Biol.
278,
147-165
|
| 28.
|
Astatke, M.,
Ng, K.,
Grindley, N. D.,
and Joyce, C. M.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
3402-3407
|
| 29.
|
Zinnen, S.,
Hsieh, J. C.,
and Modrich, P.
(1994)
J. Biol. Chem.
269,
24195-24202
|
| 30.
|
Gao, G.,
Orlova, M.,
Georgiadis, M. M.,
Hendrickson, W. A.,
and Goff, S. P.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
407-411
|
| 31.
|
Rienitz, A.,
Grosse, F.,
Blocker, H.,
Frank, R.,
and Krauss, G.
(1985)
Nucleic Acids Res.
13,
5685-5695
|
| 32.
|
Tabor, S.,
and Richardson, C. C.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
4076-4080
|
| 33.
|
Beard, W. A.,
Minnick, D. T.,
Wade, C. L.,
Prasad, R.,
Won, R. L.,
Kumar, A.,
Kunkel, T. A.,
and Wilson, S. H.
(1996)
J. Biol. Chem.
271,
12213-12220
|
| 34.
|
Astatke, M.,
Grindley, N. D. F.,
and Joyce, C. M.
(1995)
J. Biol. Chem.
270,
1945-1954
|
| 35.
|
Spence, R. A.,
Kati, W. M.,
Anderson, K. S.,
and Johnson, K. A.
(1995)
Science
267,
988-993
|
| 36.
|
Brandis, J. W.,
Edwards, S. G.,
and Johnson, K. A.
(1996)
Biochemistry
35,
2189-2200
|
| 37.
|
Lewis, D. A.,
Bebenek, K.,
Beard, W. A.,
Wilson, S. H.,
and Kunkel, T. A.
(1999)
J. Biol. Chem.
274,
32924-32930
|
| 38.
|
Boyer, P. L.,
Sarafianos, S. G.,
Arnold, E.,
and Hughes, S. H.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
3056-3061
|
| 39.
|
Kaushik, N.,
Singh, K.,
Alluru, I.,
and Modak, M. J.
(1999)
Biochemistry
38,
2617-2627
|
| 40.
|
Bonnin, A.,
Lazaro, J. M.,
Blanco, L.,
and Salas, M.
(1999)
J. Mol. Biol.
290,
241-251
|
| 41.
|
Harris, D.,
Kaushik, N.,
Pandey, P. K.,
Yadav, P. N.,
and Pandey, V. N.
(1998)
J. Biol. Chem.
273,
33624-33634
|
| 42.
|
Kaushik, N.,
Harris, D.,
Rege, N.,
Modak, M. J.,
Yadav, P. N.,
and Pandey, V. N.
(1997)
Biochemistry
36,
14430-14438
|
| 43.
|
Gutierrez-Rivas, M.,
Ibanez, A.,
Martinez, M. A.,
Domingo, E.,
and Menendez-Arias, L.
(1999)
J. Mol. Biol.
290,
615-625
|
| 44.
|
Brieba, L. G.,
and Sousa, R.
(2000)
Biochemistry
39,
919-923
|
| 45.
|
Cheetham, G. M.,
Jeruzalmi, D.,
and Steitz, T. A.
(1999)
Nature
399,
80-83
|
| 46.
|
Cheetham, G. M.,
and Steitz, T. A.
(1999)
Science
286,
2305-2309
|
| 47.
|
Rechinsky, V. O.,
Kostyuk, D. A.,
Tunitskaya, V. L.,
and Kochetkov, S. N.
(1992)
FEBS Lett.
306,
129-132
|
| 48.
|
Arnold, J. J.,
and Cameron, C. E.
(2000)
J. Biol. Chem.
275,
5329-5336
|
| 49.
|
Bailey, S.
(1994)
Acta Crystallogr. Sec. D Biol. Crystallogr.
50,
760-763
|
| 50.
|
Jones, T. A.,
Zhou, J.-Y.,
Cowan, S. W.,
and Kjeldgaard, M.
(1991)
Acta Crystallogr. Sec. D Biol. Crystallogr.
47,
110-119
|
| 51.
|
Brunger, A. T.
(1998)
Acta Crystallogr. Sec. D Biol. Crystallogr.
54,
905-921
|
| 52.
|
Berendsen, R.
(1984)
J. Chem. Phys.
81,
3684-3690
|
| 53.
|
Laskowski, R. A.,
McArthur, M. W.,
Moss, D. S.,
and Thornton, J. M.
(1993)
J. Appl. Crystallogr.
26,
283-291
|
| 54.
|
Aiyar, A.,
Xiang, Y.,
and Leis, J.
(1996)
Methods Mol. Biol.
57,
177-191
|
| 55.
|
Gohara, D. W.,
Ha, C. S.,
Ghosh, S. K. B.,
Arnold, J. J.,
Wisniewski, T. J.,
and Cameron, C. E.
(1999)
Protein Expression Purif.
17,
128-138
|
| 56.
|
Gill, S. C.,
and von Hippel, P. H.
(1989)
Anal. Biochem.
182,
319-326
|
| 57.
|
Johnson, K. A.
(1986)
Methods Enzymol.
134,
677-705
|
| 58.
|
Herold, A.,
and Andino, R.
(2000)
J. Virol.
74,
6394-6400
|
| 59.
|
Andino, R.,
Rieckhof, G. E.,
Achacoso, P. L.,
and Baltimore, D.
(1993)
EMBO J.
12,
3587-3598
|
| 60.
|
Crotty, S.,
Lohman, B. L.,
Lu, F. X.,
Tang, S.,
Miller, C. J.,
and Andino, R.
(1999)
J. Virol.
73,
9485-9495
|
| 61.
|
Richards, O. C.,
and Ehrenfeld, E.
(1997)
J. Biol. Chem.
272,
23261-23264
|
| 62.
|
Esteban, J. A.,
Salas, M.,
and Blanco, L.
(1993)
J. Biol. Chem.
268,
2719-2726
|
| 63.
|
Koonin, E. V.
(1991)
J. Gen. Virol.
72,
2197-2206
|
| 64.
|
Lohmann, V.,
Korner, F.,
Herian, U.,
and Bartenschlager, R.
(1997)
J. Virol.
71,
8416-8428
|
| 65.
|
Sankar, S.,
and Porter, A. G.
(1992)
J. Biol. Chem.
267,
10168-10176
|
| 66.
|
Nugent, C. I.,
Johnson, K. L.,
Sarnow, P.,
and Kirkegaard, K.
(1999)
J. Virol.
73,
427-435
|
| 67.
|
Fersht, A.
(1999)
Structure and Mechanism in Protein Science: A Guide to Enzyme Catalysis and Protein Engineering
, p. 30, W. H. Freeman and Co., New York
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Arias, J. J. Arnold, M. Sierra, E. D. Smidansky, E. Domingo, and C. E. Cameron
Determinants of RNA-Dependent RNA Polymerase (In)fidelity Revealed by Kinetic Analysis of the Polymerase Encoded by a Foot-and-Mouth Disease Virus Mutant with Reduced Sensitivity to Ribavirin
J. Virol.,
December 15, 2008;
82(24):
12346 - 12355.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. F. Zamyatkin, F. Parra, J. M. M. Alonso, D. A. Harki, B. R. Peterson, P. Grochulski, and K. K.-S. Ng
Structural Insights into Mechanisms of Catalysis and Inhibition in Norwalk Virus Polymerase
J. Biol. Chem.,
March 21, 2008;
283(12):
7705 - 7712.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. N. Harrison, E. V. Gazina, D. F. Purcell, D. A. Anderson, and S. Petrou
Amiloride Derivatives Inhibit Coxsackievirus B3 RNA Replication
J. Virol.,
February 1, 2008;
82(3):
1465 - 1473.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Shen, Z. J. Reitman, Y. Zhao, I. Moustafa, Q. Wang, J. J. Arnold, H. B. Pathak, and C. E. Cameron
Picornavirus Genome Replication: IDENTIFICATION OF THE SURFACE OF THE POLIOVIRUS (PV) 3C DIMER THAT INTERACTS WITH PV 3Dpol DURING VPg URIDYLYLATION AND CONSTRUCTION OF A STRUCTURAL MODEL FOR THE PV 3C2-3Dpol COMPLEX
J. Biol. Chem.,
January 11, 2008;
283(2):
875 - 888.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Garriga, A. Navarro, J. Querol-Audi, F. Abaitua, J. F. Rodriguez, and N. Verdaguer
Activation mechanism of a noncanonical RNA-dependent RNA polymerase
PNAS,
December 18, 2007;
104(51):
20540 - 20545.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. S. Korneeva and C. E. Cameron
Structure-Function Relationships of the Viral RNA-dependent RNA Polymerase: FIDELITY, REPLICATION SPEED, AND INITIATION MECHANISM DETERMINED BY A RESIDUE IN THE RIBOSE-BINDING POCKET
J. Biol. Chem.,
June 1, 2007;
282(22):
16135 - 16145.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Ferrer-Orta, A. Arias, R. Perez-Luque, C. Escarmis, E. Domingo, and N. Verdaguer
Sequential structures provide insights into the fidelity of RNA replication
PNAS,
May 29, 2007;
104(22):
9463 - 9468.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. L. Marcotte, A. B. Wass, D. W. Gohara, H. B. Pathak, J. J. Arnold, D. J. Filman, C. E. Cameron, and J. M. Hogle
Crystal Structure of Poliovirus 3CD Protein: Virally Encoded Protease and Precursor to the RNA-Dependent RNA Polymerase
J. Virol.,
April 1, 2007;
81(7):
3583 - 3596.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Jakubiec, V. Tournier, G. Drugeon, S. Pflieger, L. Camborde, J. Vinh, F. Hericourt, V. Redeker, and I. Jupin
Phosphorylation of Viral RNA-dependent RNA Polymerase and Its Role in Replication of a Plus-strand RNA Virus
J. Biol. Chem.,
July 28, 2006;
281(30):
21236 - 21249.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Arnold, M. Vignuzzi, J. K. Stone, R. Andino, and C. E. Cameron
Remote Site Control of an Active Site Fidelity Checkpoint in a Viral RNA-dependent RNA Polymerase
J. Biol. Chem.,
July 8, 2005;
280(27):
25706 - 25716.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. C. Appleby, H. Luecke, J. H. Shim, J. Z. Wu, I. W. Cheney, W. Zhong, L. Vogeley, Z. Hong, and N. Yao
Crystal Structure of Complete Rhinovirus RNA Polymerase Suggests Front Loading of Protein Primer
J. Virol.,
January 1, 2005;
79(1):
277 - 288.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Ferrer-Orta, A. Arias, R. Perez-Luque, C. Escarmis, E. Domingo, and N. Verdaguer
Structure of Foot-and-Mouth Disease Virus RNA-dependent RNA Polymerase and Its Complex with a Template-Primer RNA
J. Biol. Chem.,
November 5, 2004;
279(45):
47212 - 47221.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Crotty, M.-C. Saleh, L. Gitlin, O. Beske, and R. Andino
The Poliovirus Replication Machinery Can Escape Inhibition by an Antiviral Drug That Targets a Host Cell Protein
J. Virol.,
April 1, 2004;
78(7):
3378 - 3386.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Xu, Y. Liu, S. Weiss, E. Arnold, S. G. Sarafianos, and J. Ding
Molecular model of SARS coronavirus polymerase: implications for biochemical functions and drug design
Nucleic Acids Res.,
December 15, 2003;
31(24):
7117 - 7130.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. W. Cheney, S. Naim, J. H. Shim, M. Reinhardt, B. Pai, J. Z. Wu, Z. Hong, and W. Zhong
Viability of Poliovirus/Rhinovirus VPg Chimeric Viruses and Identification of an Amino Acid Residue in the VPg Gene Critical for Viral RNA Replication
J. Virol.,
July 1, 2003;
77(13):
7434 - 7443.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. K. Pfeiffer and K. Kirkegaard
A single mutation in poliovirus RNA-dependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity
PNAS,
June 10, 2003;
100(12):
7289 - 7294.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Crotty, D. Gohara, D. K. Gilligan, S. Karelsky, C. E. Cameron, and R. Andino
Manganese-Dependent Polioviruses Caused by Mutations within the Viral Polymerase
J. Virol.,
May 1, 2003;
77(9):
5378 - 5388.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. B. Pathak, S. K. B. Ghosh, A. W. Roberts, S. D. Sharma, J. D. Yoder, J. J. Arnold, D. W. Gohara, D. J. Barton, A. V. Paul, and C. E. Cameron
Structure-Function Relationships of the RNA-dependent RNA Polymerase from Poliovirus (3Dpol). A SURFACE OF THE PRIMARY OLIGOMERIZATION DOMAIN FUNCTIONS IN CAPSID PRECURSOR PROCESSING AND VPg URIDYLYLATION
J. Biol. Chem.,
August 23, 2002;
277(35):
31551 - 31562.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Crotty, L. Hix, L. J. Sigal, and R. Andino
Poliovirus pathogenesis in a new poliovirus receptor transgenic mouse model: age-dependent paralysis and a mucosal route of infection
J. Gen. Virol.,
June 1, 2002;
83(7):
1707 - 1720.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Crotty, C. J. Miller, B. L. Lohman, M. R. Neagu, L. Compton, D. Lu, F. X.-S. Lu, L. Fritts, J. D. Lifson, and R. Andino
Protection against Simian Immunodeficiency Virus Vaginal Challenge by Using Sabin Poliovirus Vectors
J. Virol.,
August 15, 2001;
75(16):
7435 - 7452.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Crotty, C. E. Cameron, and R. Andino
RNA virus error catastrophe: Direct molecular test by using ribavirin
PNAS,
May 18, 2001;
(2001)
111085598.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
L. Wei, J. S. Huhn, A. Mory, H. B. Pathak, S. V. Sosnovtsev, K. Y. Green, and C. E. Cameron
Proteinase-Polymerase Precursor as the Active Form of Feline Calicivirus RNA-Dependent RNA Polymerase
J. Virol.,
February 1, 2001;
75(3):
1211 - 1219.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. K. S. Ng, M. M. Cherney, A. L. Vazquez, A. Machin, J. M. M. Alonso, F. Parra, and M. N. G. James
Crystal Structures of Active and Inactive Conformations of a Caliciviral RNA-dependent RNA Polymerase
J. Biol. Chem.,
January 4, 2002;
277(2):
1381 - 1387.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Crotty, C. E. Cameron, and R. Andino
RNA virus error catastrophe: Direct molecular test by using ribavirin
PNAS,
June 5, 2001;
98(12):
6895 - 6900.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|